Hims & Hers Health (HIMS) Change in Account Payables (2019 - 2026)
Hims & Hers Health (HIMS) reported Change in Account Payables of $167.6 million for Q1 2026, up 1058.32% on a YoY basis from $14.5 million in Q1 2025, and up 466.02% sequentially from -$45.8 million in Q4 2025.
Hims & Hers Health (HIMS) Change in Account Payables (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Change in Account Payables data on file, last reported at $167.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 1058.32% year-over-year to $167.6 million; the trailing twelve-month figure through Mar 2026 stood at $183.5 million (up 236.14% YoY), and the FY2025 full-year result was $30.3 million, down 30.69% from the prior year.
- Change in Account Payables grew to $167.6 million in Q1 2026, from -$45.8 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $167.6 million in Q1 2026 to a low of -$45.8 million in Q4 2025.
- A 5-year average of $15.4 million and a median of $4.0 million in 2023 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables jumped 1922.18% in 2024 and tumbled 629.0% in 2025, its largest moves.
- Tracing HIMS's Change in Account Payables over 5 years: stood at -$609000.0 in 2022, then jumped by 579.97% to $2.9 million in 2023, then soared by 196.2% to $8.7 million in 2024, then plunged by 629.0% to -$45.8 million in 2025, then surged by 466.02% to $167.6 million in 2026.
- Business Quant data shows HIMS's Change in Account Payables at $167.6 million in Q1 2026, -$45.8 million in Q4 2025, and $71.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 167.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 167.64 Mn |
| Mar 31, 2026 | 167.64 Mn |
| Dec 31, 2025 | -45.80 Mn |
| Dec 31, 2025 | -45.80 Mn |
| Sep 30, 2025 | 70.95 Mn |
| Sep 30, 2025 | 70.95 Mn |
| Jun 30, 2025 | -9.33 Mn |
| Jun 30, 2025 | -9.33 Mn |
| Mar 31, 2025 | 14.47 Mn |
| Mar 31, 2025 | 14.47 Mn |
| Dec 31, 2024 | 8.66 Mn |
| Dec 31, 2024 | 8.66 Mn |
| Sep 30, 2024 | 18.90 Mn |
| Sep 30, 2024 | 18.90 Mn |
| Jun 30, 2024 | 12.55 Mn |
| Jun 30, 2024 | 12.55 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Dec 31, 2023 | 2.92 Mn |
| Dec 31, 2023 | 2.92 Mn |